This is an old revision of this page, as edited by ProteinBoxBot(talk | contribs) at 14:55, 20 May 2016(Updating to new gene infobox populated via wikidata). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 14:55, 20 May 2016 by ProteinBoxBot(talk | contribs)(Updating to new gene infobox populated via wikidata)
Patients with idiopathicachalasia show a significant difference in the distribution of SNPs affecting VIPR1.[11]
VIP and PACAP levels were decreased in anterior vaginal wall of stress urinary incontinence and pelvic organ prolapse patients, they may participate in the pathophysiology of these diseases.[12]
^Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S (Apr 1992). "Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide". Neuron. 8 (4): 811–9. doi:10.1016/0896-6273(92)90101-I. PMID1314625.
^Usdin TB, Bonner TI, Mezey E (Dec 1994). "Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions". Endocrinology. 135 (6): 2662–80. doi:10.1210/en.135.6.2662. PMID7988457.
^Nam C, Case AJ, Hostager BS, O'Dorisio MS (Feb 2009). "The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation". Journal of Molecular Neuroscience. 37 (2): 160–7. doi:10.1007/s12031-008-9119-x. PMID18663606.
^Freson K, Peeters K, De Vos R, Wittevrongel C, Thys C, Hoylaerts MF, Vermylen J, Van Geet C (Feb 2008). "PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications". Blood. 111 (4): 1885–93. doi:10.1182/blood-2007-06-098558. PMID18000164.
^Paladini F, Cocco E, Cascino I, Belfiore F, Badiali D, Piretta L, Alghisi F, Anzini F, Fiorillo MT, Corazziari E, Sorrentino R (Jun 2009). "Age-dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene". Neurogastroenterology and Motility. 21 (6): 597–602. doi:10.1111/j.1365-2982.2009.01284.x. PMID19309439.
^Hong X, Huang L, Song Y (Aug 2008). "Role of vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide in the vaginal wall of women with stress urinary incontinence and pelvic organ prolapse". International Urogynecology Journal and Pelvic Floor Dysfunction. 19 (8): 1151–7. doi:10.1007/s00192-008-0585-z. PMID18351280.
Further reading
"[Quaternary structure of rabbit skeletal muscle glycogen synthetase]". Doklady Akademii Nauk SSSR. 222 (4): 997–1000. Jun 1975. PMID807467. {{cite journal}}: Unknown parameter |trans_title= ignored (|trans-title= suggested) (help)
Couvineau A, Gaudin P, Maoret JJ, Rouyer-Fessard C, Nicole P, Laburthe M (Jan 1995). "Highly conserved aspartate 68, tryptophane 73 and glycine 109 in the N-terminal extracellular domain of the human VIP receptor are essential for its ability to bind VIP". Biochemical and Biophysical Research Communications. 206 (1): 246–52. doi:10.1006/bbrc.1995.1034. PMID7818527.
Gagnon AW, Aiyar N, Elshourbagy NA (Mar 1994). "Molecular cloning and functional characterization of a human liver vasoactive intestinal peptide receptor". Cellular Signalling. 6 (3): 321–33. doi:10.1016/0898-6568(94)90037-X. PMID7917790.
Sreedharan SP, Patel DR, Xia M, Ichikawa S, Goetzl EJ (Aug 1994). "Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways". Biochemical and Biophysical Research Communications. 203 (1): 141–8. doi:10.1006/bbrc.1994.2160. PMID8074647.
Couvineau A, Rouyer-Fessard C, Darmoul D, Maoret JJ, Carrero I, Ogier-Denis E, Laburthe M (Apr 1994). "Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains". Biochemical and Biophysical Research Communications. 200 (2): 769–76. doi:10.1006/bbrc.1994.1517. PMID8179610.
Sreedharan SP, Patel DR, Huang JX, Goetzl EJ (Jun 1993). "Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor". Biochemical and Biophysical Research Communications. 193 (2): 546–53. doi:10.1006/bbrc.1993.1658. PMID8390245.
Couvineau A, Fabre C, Gaudin P, Maoret JJ, Laburthe M (Feb 1996). "Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane". Biochemistry. 35 (6): 1745–52. doi:10.1021/bi952022h. PMID8639654.
Pozo D, Guerrero JM, Segura JJ, Calvo JR (Sep 1996). "Thymosin alpha 1 interacts with the VIP receptor-effector system in rat and mouse immunocompetent cells". Immunopharmacology. 34 (2–3): 113–23. doi:10.1016/0162-3109(96)00131-2. PMID8886855.
Couvineau A, Maoret JJ, Rouyer-Fessard C, Carrero I, Laburthe M (Dec 1998). "Cloning and functional characterization of the human VIP1/PACAP receptor promoter". Annals of the New York Academy of Sciences. 865: 59–63. doi:10.1111/j.1749-6632.1998.tb11163.x. PMID9927997.
Knudsen SM, Tams JW, Wulff BS, Fahrenkrug J (Dec 1998). "Importance of conserved cysteines in the extracellular loops of human PACAP/VIP1 receptor for ligand binding and stimulation of cAMP production". Annals of the New York Academy of Sciences. 865: 259–65. doi:10.1111/j.1749-6632.1998.tb11186.x. PMID9928020.
Marie J, Wakkach A, Coudray A, Chastre E, Berrih-Aknin S, Gespach C (Feb 1999). "Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients". Journal of Immunology. 162 (4): 2103–12. PMID9973484.
Mimuro H, Suzuki T, Suetsugu S, Miki H, Takenawa T, Sasakawa C (Sep 2000). "Profilin is required for sustaining efficient intra- and intercellular spreading of Shigella flexneri". The Journal of Biological Chemistry. 275 (37): 28893–901. doi:10.1074/jbc.M003882200. PMID10867004.{{cite journal}}: CS1 maint: unflagged free DOI (link)
Nicole P, Maoret JJ, Couvineau A, Momany FA, Laburthe M (Sep 2000). "Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding". Biochemical and Biophysical Research Communications. 276 (2): 654–9. doi:10.1006/bbrc.2000.3375. PMID11027527.
Bajo AM, Juarranz MG, Valenzuela P, Martínez P, Prieto JC, Guijarro LG (Sep 2000). "Expression of vasoactive intestinal peptide (VIP) receptors in human uterus". Peptides. 21 (9): 1383–8. doi:10.1016/S0196-9781(00)00282-5. PMID11072126.
Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B (Feb 2001). "Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells". Journal of Immunology. 166 (4): 2522–30. doi:10.4049/jimmunol.166.4.2522. PMID11160313.
Martin Shreeve S (Feb 2002). "Identification of G-proteins coupling to the vasoactive intestinal peptide receptor VPAC(1) using immunoaffinity chromatography: evidence for precoupling". Biochemical and Biophysical Research Communications. 290 (4): 1300–7. doi:10.1006/bbrc.2002.6342. PMID11812005.
Dorsam G, Goetzl EJ (Apr 2002). "Vasoactive intestinal peptide receptor-1 (VPAC-1) is a novel gene target of the hemolymphopoietic transcription factor Ikaros". The Journal of Biological Chemistry. 277 (16): 13488–93. doi:10.1074/jbc.M107922200. PMID11812772.{{cite journal}}: CS1 maint: unflagged free DOI (link)
Branch DR, Valenta LJ, Yousefi S, Sakac D, Singla R, Bali M, Sahai BM, Ma XZ (Feb 2002). "VPAC1 is a cellular neuroendocrine receptor expressed on T cells that actively facilitates productive HIV-1 infection". AIDS. 16 (3): 309–19. doi:10.1097/00002030-200202150-00001. PMID11834941.